discussion

2
30. Yan T, Zhang G, Li B, Han L, Zang J, Li L, et al. Prediction of coronary artery disease in patients undergoing operations for rheumatic aortic valve disease. Clin Cardiol. 2012;35:707-11. 31. Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, et al. Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med. 2008;359:2324-36. 32. Mollet NR, Cademartiri F, Van Mieghem CAG, Runza G, McFadden EP, Baks T, et al. High-resolution spiral computed tomography coronary angiography in patients referred for diagnostic conventional coronary angiography. Circulation. 2005;112:2318-23. 33. Meijboom WB, Mollet NR, Van Mieghem CAG, Kluin J, Weustink AC, Pugliese F, et al. Pre-operative computed tomography coronary angiography to detect significant coronary artery disease in patients referred for cardiac valve surgery. J Am Coll Cardiol. 2006;48:1658-65. Discussion Dr Jennifer Sue Lawton (St Louis, Mo). Congratulations on very nice, very useful work and a very nice presentation. I really enjoyed your algorithm and the specificity for the different types of valve pathology. As you know, we do not know the incidence of significant CAD in the general population, and the study you quoted from the New England Journal of Medicine by Patel et al—they did not include valve surgery patients, and they used different criteria for significant CAD. Your criterion was greater than 50% stenosis in an epicardial vessel and theirs was 70% or 50% in the left main. They reported on 400,000 patients, approxi- mately, about one third of whom were asymptomatic but had disease, but for some reason those patients had undergone cardiac catheterization. Similarly, in the 2008 updates of the American Heart Association guidelines, they state that in an asymptomatic population, the incidence is approximately 4%. So, with that in mind, looking at your stratification of your study population, 752 patients were ruled out fairly soon if they had not undergone preoperative catheterization within 6 months of the valve surgery. Thus, for those patients, I have a question, if you have the data, about them, because in your report you did mention that a few of them had had MI or PCI before valve surgery. So, did they not un- dergo cardiac catheterization before surgery by surgeon preference or were they young patients with mitral regurgitation? If you have any data on those patients, because, with that in mind, your estima- tion of risk and your conclusions might have been underestimated or overestimated. That is my first question. Dr Thalji. Thank you very much for your comments, Dr Law- ton, and for your very insightful question. You raise an important point. Specifically, that a subset of patients that was excluded, owing to the absence of preoperative angiography within 6 months of surgery, did indeed have symptoms of angina, previous PCI, or previous MI. There are several potential explanations for this. First, we defined preoperative angiography as being within 6 months of the index surgery. Some patients had undergone preop- erative angiography that was performed beyond this period; for instance, within 6 months to 1 year. However, after consultation with the cardiologists and cardiac surgeons, angiography performed more than 6 months before surgery were deemed less likely to be representative of the baseline burden of CAD. Furthermore, it is also worthwhile noting that about 20% of the patients who did not undergo conventional invasive angiography did alternatively undergo computed tomography coronary angiog- raphy. Most of these patients were those undergoing robotic mitral valve repair, which, at our institution, is performed by Drs Rakesh Suri and Harold Burkhart. It is standard practice at our institution for all patients who undergo robotic cardiac surgery to undergo computed tomography of the chest, abdomen, and pelvis to assess for underlying vascular disease, including coronary stenosis. It is, therefore, possible that these patients who had had MI, PCI, or angina had been assessed by a computed tomographic angiogram, which proved to be negative, hence circumventing the need for conventional angiography. Dr Lawton. Do you have data for those 752 patients and whether any of them did undergo concomitant CABG with valve surgery? Dr Thalji. That is a good question. Yes, that is correct. Appro- ximately 25 patients without angiography within 6 months of surgery did require concomitant CABG. The situation for these patients, as before, was such that the surgeons believed that CCA more than 6 months before surgery was sufficient to guide surgical practice and perform concomitant CABG. This highlights that our algorithms are simply guides and do not outweigh the sound clinical judgment of the surgeon. Dr Lawton. My next question is, sort of as a devil’s advocate, a number of surgeons are cautious and very conservative; thus, how would you convince such surgeons to forego cardiac cathete- rization preoperatively when we know additional data can be gained from the study? It often provides a very nice look at the ascending aorta and an assessment of left ventricular function. Additional find- ings could be that that the patient has anomalous coronary anatomy, such as a double-barrel left main, which could become important, depending on your cardioplegia strategy. Similarly, if the patient is right dominant and you plan a very long mitral repair, perhaps that will not work and requires a replacement and you have only given retrograde cardioplegia. A number of scenarios are possible, so how could you convince us we do not need that information? Dr Thalji. That is a great question, and there are several points to be made. First, with the pending approval of the Affordable Care Act, we will all be called on to scrutinize our actions and assess the associated costs. Our current investigation is the first step of multiple studies that are forthcoming to determine whether we are overusing coronary angiography. However, are we suggesting that surgeons should abandon angiography altogether? No, we do not believe this should be the case. What we are suggesting is that perhaps subsets of patients who specifically are at a low risk of CAD might be able to either forego invasive angiography or, alternatively, undergo other less-invasive investigative procedures to evaluate coronary obstruction. For instance, ventricular function can potentially be assessed using echocardiography. To delineate the coronary anatomy, computed tomography coronary angiog- raphy has become a very popular topic examined in contemporary studies. I think it is going to take a bit of time before we see a marked shift in investigative habits; however, we need to start being self-critical of our clinical practice and to evaluate the effect it has on patient safety and on healthcare economics. Dr David C. McGiffin (Birmingham, Ala). Has there been any change at the clinic since this information, and if so, what do you do now? Dr Thalji. To date, what we can say is that there has been a change in our mind sets. Specifically, we have come to appreciate that a large divide exists between what we are currently doing and perhaps what we should be doing. Importantly, validation of our models in external populations is a critical and necessary step Thalji et al Acquired Cardiovascular Disease The Journal of Thoracic and Cardiovascular Surgery c Volume 146, Number 5 1063 ACD

Upload: truongdang

Post on 30-Dec-2016

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Discussion

Thalji et al Acquired Cardiovascular Disease

30. Yan T, Zhang G, Li B, Han L, Zang J, Li L, et al. Prediction of coronary artery

disease in patients undergoing operations for rheumatic aortic valve disease.

Clin Cardiol. 2012;35:707-11.

31. Miller JM, Rochitte CE, Dewey M, Arbab-Zadeh A, Niinuma H, Gottlieb I, et al.

Diagnostic performance of coronary angiography by 64-row CT. N Engl J Med.

2008;359:2324-36.

32. Mollet NR, Cademartiri F, Van Mieghem CAG, Runza G, McFadden EP, Baks T,

et al. High-resolution spiral computed tomography coronary angiography in

patients referred for diagnostic conventional coronary angiography. Circulation.

2005;112:2318-23.

33. Meijboom WB, Mollet NR, Van Mieghem CAG, Kluin J, Weustink AC,

Pugliese F, et al. Pre-operative computed tomography coronary angiography to

detect significant coronary artery disease in patients referred for cardiac valve

surgery. J Am Coll Cardiol. 2006;48:1658-65.

ACD

DiscussionDr Jennifer Sue Lawton (St Louis, Mo). Congratulations on

very nice, very useful work and a very nice presentation. I reallyenjoyed your algorithm and the specificity for the different typesof valve pathology. As you know, we do not know the incidenceof significant CAD in the general population, and the study youquoted from the New England Journal of Medicine by Patel etal—they did not include valve surgery patients, and they useddifferent criteria for significant CAD. Your criterion was greaterthan 50% stenosis in an epicardial vessel and theirs was 70% or50% in the left main. They reported on 400,000 patients, approxi-mately, about one third of whom were asymptomatic but haddisease, but for some reason those patients had undergone cardiaccatheterization. Similarly, in the 2008 updates of the AmericanHeart Association guidelines, they state that in an asymptomaticpopulation, the incidence is approximately 4%. So, with that inmind, looking at your stratification of your study population, 752patients were ruled out fairly soon if they had not undergonepreoperative catheterization within 6 months of the valve surgery.Thus, for those patients, I have a question, if you have the data,about them, because in your report you did mention that a few ofthem had had MI or PCI before valve surgery. So, did they not un-dergo cardiac catheterization before surgery by surgeon preferenceor were they young patients with mitral regurgitation? If you haveany data on those patients, because, with that in mind, your estima-tion of risk and your conclusions might have been underestimatedor overestimated. That is my first question.

Dr Thalji. Thank you very much for your comments, Dr Law-ton, and for your very insightful question. You raise an importantpoint. Specifically, that a subset of patients that was excluded,owing to the absence of preoperative angiography within 6 monthsof surgery, did indeed have symptoms of angina, previous PCI, orprevious MI. There are several potential explanations for this.

First, we defined preoperative angiography as being within 6months of the index surgery. Some patients had undergone preop-erative angiography that was performed beyond this period; forinstance, within 6 months to 1 year. However, after consultationwith the cardiologists and cardiac surgeons, angiographyperformed more than 6 months before surgery were deemed lesslikely to be representative of the baseline burden of CAD.

Furthermore, it is also worthwhile noting that about 20% of thepatients who did not undergo conventional invasive angiographydid alternatively undergo computed tomography coronary angiog-raphy. Most of these patients were those undergoing robotic mitralvalve repair, which, at our institution, is performed by Drs Rakesh

The Journal of Thoracic and Car

Suri and Harold Burkhart. It is standard practice at our institutionfor all patients who undergo robotic cardiac surgery to undergocomputed tomography of the chest, abdomen, and pelvis to assessfor underlying vascular disease, including coronary stenosis. It is,therefore, possible that these patients who had had MI, PCI, orangina had been assessed by a computed tomographic angiogram,which proved to be negative, hence circumventing the need forconventional angiography.

Dr Lawton. Do you have data for those 752 patients andwhether any of them did undergo concomitant CABG with valvesurgery?

Dr Thalji. That is a good question. Yes, that is correct. Appro-ximately 25 patients without angiography within 6 months ofsurgery did require concomitant CABG. The situation for thesepatients, as before, was such that the surgeons believed thatCCA more than 6 months before surgery was sufficient to guidesurgical practice and perform concomitant CABG. This highlightsthat our algorithms are simply guides and do not outweigh thesound clinical judgment of the surgeon.

Dr Lawton.My next question is, sort of as a devil’s advocate, anumber of surgeons are cautious and very conservative; thus,how would you convince such surgeons to forego cardiac cathete-rization preoperatively whenwe know additional data can be gainedfrom the study? It often provides a very nice look at the ascendingaorta and an assessment of left ventricular function. Additional find-ings could be that that the patient has anomalous coronary anatomy,such as a double-barrel left main, which could become important,depending on your cardioplegia strategy. Similarly, if the patient isright dominant and you plan a very long mitral repair, perhaps thatwill not work and requires a replacement and you have only givenretrograde cardioplegia. A number of scenarios are possible, sohow could you convince us we do not need that information?

Dr Thalji. That is a great question, and there are several pointsto be made. First, with the pending approval of the Affordable CareAct, wewill all be called on to scrutinize our actions and assess theassociated costs. Our current investigation is the first step ofmultiple studies that are forthcoming to determine whether weare overusing coronary angiography. However, are we suggestingthat surgeons should abandon angiography altogether? No, we donot believe this should be the case. What we are suggesting is thatperhaps subsets of patients who specifically are at a low risk ofCAD might be able to either forego invasive angiography or,alternatively, undergo other less-invasive investigative proceduresto evaluate coronary obstruction. For instance, ventricular functioncan potentially be assessed using echocardiography. To delineatethe coronary anatomy, computed tomography coronary angiog-raphy has become a very popular topic examined in contemporarystudies. I think it is going to take a bit of time before we see amarked shift in investigative habits; however, we need to startbeing self-critical of our clinical practice and to evaluate the effectit has on patient safety and on healthcare economics.

Dr David C. McGiffin (Birmingham, Ala). Has there been anychange at the clinic since this information, and if so, what do youdo now?

Dr Thalji. To date, what we can say is that there has been achange in our mind sets. Specifically, we have come to appreciatethat a large divide exists between what we are currently doing andperhaps what we should be doing. Importantly, validation of ourmodels in external populations is a critical and necessary step

diovascular Surgery c Volume 146, Number 5 1063

Page 2: Discussion

Acquired Cardiovascular Disease Thalji et al

ACD

that needs to be undertaken before we should drastically alter ourclinical practice.

Dr McGiffin. So it has not translated into a change yet?Dr Thalji. To date, it has not.Dr Shyam Kolvekar (London, United Kingdom). I enjoyed

your report, and I think your risks come with these problems.I have 2 small questions. One, did you prefer stress echocardiog-raphy compared to computed tomography angiography to findthe patients who do not have a high risk and to determinewhether they have any obstructive disease, because it is less inva-sive? The second question is, did you have any complicationswith your angiography patients where they had morbidity ormortality?

Dr Thalji. Thank you for your questions. Regarding your firstquestion, you are correct, the published data have shown that stressechocardiography can be leveraged to obtain valuable informationregarding the coronary disease burden. Although stress echocar-diography is a less-invasive option, as a general rule of thumb,clinicians have tended to have a greater peace of mind whenthe coronary anatomy has been visualized, such as is the casewith angiography. These are certainly factors that merit consider-ation when determining which preoperative investigations toperform.

Regarding your second question, in terms of complications, wedo not have that data available for our population at the moment.

1064 The Journal of Thoracic and Cardiovascular Sur

However, we can allude to previously published data detailingthat the rate of major complications at invasive angiography isapproximately 2%. However, as I said, we do not have that datafor our patients specifically.

Dr Rakesh M. Suri (Rochester, Minn). Just to comment onNassir’s very thoughtful answer and to respond to 1 of the lastquestions. This is a large, retrospective population-based study,and it was not designed to answer the specific question—ifcoronary angiography is avoided, which surrogate tests or whichreplacement tests should be ordered instead—that is a topic thatwill be addressed in forthcoming investigations. We will be betterprepared to answer that as we move forward.

Dr A. Pieter Kappetein (Rotterdam, The Netherlands). Didyou consider the type of valvular heart disease, whether thatmade a difference, whether it was stenotic, aortic valve disease,or insufficiency?

Dr Thalji. That is a good question. We have not presentedsuch data. Nevertheless, in a subset analysis, we found thataortic stenosis was an important variable predictive of underly-ing significant CAD. Similarly, and as we have documented inour study, patients undergoing AVS—the vast majority ofwhom had aortic stenosis—(1) were more likely to havecoexistent CAD, and (2) were found to have coronary stenosisat a much younger age compared with those undergoing MVSor SM.

gery c November 2013